Top

Published in:

01-04-2017 | Original Article

Role of Glibenclamide in Brain Injury After Intracerebral Hemorrhage

Authors: Bing Jiang, Lin Li, Qianwei Chen, Yihao Tao, Liming Yang, Bo Zhang, John H. Zhang, Hua Feng, Zhi Chen, Jun Tang, Gang Zhu

Published in: Translational Stroke Research | Issue 2/2017

Abstract

Brain edema following intracerebral hemorrhage (ICH) causes severe secondary brain injury, and no efficient pharmacological preventions are available. The present study was designed to demonstrate the neuroprotective effects of glibenclamide on brain edema and key factors of the blood–brain barrier (BBB). The study was divided into two parts. First, we utilized an autoblood-induced rat model to investigate the expression of sulfonylurea receptor 1 (Sur1). Second, rats were randomized into sham, vehicle, and glibenclamide groups. Neurological scores, brain water content, Evans blue extravasation, Morris water maze test, western blots, and immunofluorescence were used to study the effects of glibenclamide. The expression of the Sur1-Trpm4 channel but not the Sur1-KATP channel was increased in the perihematomal tissue following ICH. Glibenclamide administration significantly decreased the brain water content, restored the BBB, and reduced the expression of MMPs. In addition, glibenclamide improved long-term cognitive deficits following ICH. Glibenclamide protected BBB integrity and improved neurological outcomes after ICH by inhibiting the Sur1-Trpm4 channel, which reduces the expression of MMPs and thereby increases BBB tight-junction protein levels. Glibenclamide may have potential to protect the BBB after ICH.

Xi G, Keep RF, Hoff JT. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg. 1998;89(6):991–6. doi:10.3171/jns. 1998.89.6.0991.CrossRefPubMed

Yang GY, Betz AL, Chenevert TL, Brunberg JA, Hoff JT. Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J Neurosurg. 1994;81(1):93–102. doi:10.3171/jns. 1994.81.1.0093.CrossRefPubMed

Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. The Lancet Neurology. 2006;5(1):53–63. doi:10.1016/S1474-4422(05)70283-0.CrossRefPubMed

Shi Y, Leak RK, Keep RF, Chen J. Translational stroke research on blood-brain barrier damage: challenges, perspectives, and goals. Translational stroke research. 2016;7(2):89–92. doi:10.1007/s12975-016-0447-9.CrossRefPubMed

Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16(1):1–13. doi:10.1016/j.nbd. 2003.12.016.CrossRefPubMed

Bodmer D, Vaughan KA, Zacharia BE, Hickman ZL, Connolly ES. The molecular mechanisms that promote edema after intracerebral hemorrhage. Translational Stroke Research. 2012;3(Suppl 1):52–61. doi:10.1007/s12975-012-0162-0.CrossRefPubMed

Shin JW, Kang HC, Shim J, Sohn NW. Scutellaria baicalensis attenuates blood-brain barrier disruption after intracerebral hemorrhage in rats. The American Journal of Chinese Medicine. 2012;40(1):85–96. doi:10.1142/S0192415X12500073.CrossRefPubMed

Marble A. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents? Drugs. 1971;1(2):109–15.CrossRefPubMed

Chen M, Dong Y, Simard JM. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. J Neurosci Off J Soc Neurosci. 2003;23(24):8568–77.

10.

Simard JM, Tsymbalyuk N, Tsymbalyuk O, Ivanova S, Yurovsky V, Gerzanich V. Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke. Stroke; a journal of cerebral circulation. 2010;41(3):531–7. doi:10.1161/STROKEAHA.109.572644.CrossRefPubMedCentral

11.

Simard JM, Tsymbalyuk O, Ivanov A, Ivanova S, Bhatta S, Geng Z, et al. Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J Clin Invest. 2007;117(8):2105–13. doi:10.1172/JCI32041.CrossRefPubMedPubMedCentral

12.

Thompson EM, Pishko GL, Muldoon LL, Neuwelt EA. Inhibition of SUR1 decreases the vascular permeability of cerebral metastases. Neoplasia. 2013;15(5):535–43. doi:10.1593/neo.13164.CrossRefPubMedPubMedCentral

13.

Simard JM, Woo SK, Bhatta S, Gerzanich V. Drugs acting on SUR1 to treat CNS ischemia and trauma. Curr Opin Pharmacol. 2008;8(1):42–9. doi:10.1016/j.coph. 2007.10.004.CrossRefPubMed

14.

Simard JM, Geng Z, Woo SK, Ivanova S, Tosun C, Melnichenko L, et al. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2009;29(2):317–30. doi:10.1038/jcbfm. 2008.120.CrossRef

15.

Sheth KN. Novel approaches to the primary prevention of edema after ischemia. Stroke; a journal of cerebral circulation. 2013;44(6 Suppl 1):S136. doi:10.1161/STROKEAHA.113.001821.CrossRef

16.

Simard JM, Geng Z, Silver FL, Sheth KN, Kimberly WT, Stern BJ, et al. Does inhibiting Sur1 complement rt-PA in cerebral ischemia? Ann N Y Acad Sci. 2012;1268:95–107. doi:10.1111/j.1749-6632. 2012.06705.x.CrossRefPubMedPubMedCentral

17.

Tan Q, Chen Q, Niu Y, Feng Z, Li L, Tao Y, et al. Urokinase, a promising candidate for fibrinolytic therapy for intracerebral hemorrhage. J Neurosurg. 2016:1–10. doi:10.3171/2016.1.JNS152287.

18.

Schlunk F, Greenberg SM. The pathophysiology of intracerebral hemorrhage formation and expansion. Translational stroke research. 2015;6(4):257–63. doi:10.1007/s12975-015-0410-1.CrossRefPubMed

19.

Simard JM, Woo SK, Tsymbalyuk N, Voloshyn O, Yurovsky V, Ivanova S, et al. Glibenclamide-10-h treatment window in a clinically relevant model of stroke. Translational stroke research. 2012;3(2):286–95. doi:10.1007/s12975-012-0149-x.CrossRefPubMedPubMedCentral

20.

Li L, Tao Y, Tang J, Chen Q, Yang Y, Feng Z, et al. A cannabinoid receptor 2 agonist prevents thrombin-induced blood-brain barrier damage via the inhibition of microglial activation and matrix metalloproteinase expression in rats. Translational stroke research. 2015;6(6):467–77. doi:10.1007/s12975-015-0425-7.CrossRefPubMed

21.

Tang J, Chen Q, Guo J, Yang L, Tao Y, Li L, et al. Minocycline attenuates neonatal germinal-matrix-hemorrhage-induced neuroinflammation and brain edema by activating cannabinoid receptor 2. Mol Neurobiol. 2015; doi:10.1007/s12035-015-9154-x.

22.

Chen Q, Zhang J, Guo J, Tang J, Tao Y, Li L, et al. Chronic hydrocephalus and perihematomal tissue injury developed in a rat model of intracerebral hemorrhage with ventricular extension. Translational stroke research. 2015;6(2):125–32. doi:10.1007/s12975-014-0367-5.CrossRefPubMed

23.

Chen Y, Zhang Y, Tang J, Liu F, Hu Q, Luo C, et al. Norrin protected blood-brain barrier via frizzled-4/beta-catenin pathway after subarachnoid hemorrhage in rats. Stroke; a journal of cerebral circulation. 2015;46(2):529–36. doi:10.1161/STROKEAHA.114.007265.CrossRef

24.

Tang J, Tao Y, Jiang B, Chen Q, Hua F, Zhang J, et al. Pharmacological preventions of brain injury following experimental germinal matrix hemorrhage: an up-to-date review. Translational stroke research. 2016;7(1):20–32. doi:10.1007/s12975-015-0432-8.CrossRefPubMed

25.

Zarruk JG, Fernandez-Lopez D, Garcia-Yebenes I, Garcia-Gutierrez MS, Vivancos J, Nombela F, et al. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. Stroke; a journal of cerebral circulation. 2012;43(1):211–9. doi:10.1161/STROKEAHA.111.631044.CrossRef

26.

Tao Y, Tang J, Chen Q, Guo J, Li L, Yang L, et al. Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model. Brain Res. 2015;1602:127–35. doi:10.1016/j.brainres. 2015.01.025.CrossRefPubMed

27.

Chen Z, Gao C, Hua Y, Keep RF, Muraszko K, Xi G. Role of iron in brain injury after intraventricular hemorrhage. Stroke; a journal of cerebral circulation. 2011;42(2):465–70. doi:10.1161/STROKEAHA.110.602755.CrossRef

28.

Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848–58. doi:10.1038/nprot. 2006.116.CrossRefPubMedPubMedCentral

29.

Shohami E, Novikov M, Bass R. Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res. 1995;674(1):55–62.CrossRefPubMed

30.

Simard JM, Yurovsky V, Tsymbalyuk N, Melnichenko L, Ivanova S, Gerzanich V. Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Stroke; a journal of cerebral circulation. 2009;40(2):604–9. doi:10.1161/STROKEAHA.108.522409.CrossRef

31.

Wass CT, Lanier WL. Glucose modulation of ischemic brain injury: review and clinical recommendations. Mayo Clin Proc. 1996;71(8):801–12. doi:10.1016/S0025-6196(11)64847-7.CrossRefPubMed

32.

Zhou Y, Fathali N, Lekic T, Tang J, Zhang JH. Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats. Brain Res. 2009;1270:131–9. doi:10.1016/j.brainres. 2009.03.010.CrossRefPubMed

33.

Simard JM, Woo SK, Norenberg MD, Tosun C, Chen Z, Ivanova S, et al. Brief suppression of Abcc 8 prevents autodestruction of spinal cord after trauma. Sci Transl Med. 2010;2(28):28ra9. doi:10.1126/scitranslmed.3000522.CrossRef

34.

Simard JM, Chen M, Tarasov KV, Bhatta S, Ivanova S, Melnitchenko L, et al. Newly expressed SUR1-regulated NC (Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med. 2006;12(4):433–40. doi:10.1038/nm 1390.CrossRefPubMedPubMedCentral

35.

Tosun C, Kurland DB, Mehta R, Castellani RJ, deJong JL, Kwon MS, et al. Inhibition of the Sur1-Trpm 4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke; a journal of cerebral circulation. 2013;44(12):3522–8. doi:10.1161/STROKEAHA.113.002904.CrossRefPubMedCentral

36.

Simard JM, Sheth KN, Kimberly WT, Stern BJ, del Zoppo GJ, Jacobson S, et al. Glibenclamide in cerebral ischemia and stroke. Neurocrit Care. 2014;20(2):319–33. doi:10.1007/s12028-013-9923-1.CrossRefPubMedPubMedCentral

37.

Woo SK, Kwon MS, Ivanov A, Gerzanich V, Simard JM. The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm 4) channel. J Biol Chem. 2013;288(5):3655–67. doi:10.1074/jbc.M112.428219.CrossRefPubMed

38.

Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37(1):13–25. doi:10.1016/j.nbd. 2009.07.030.CrossRefPubMed

39.

Chen M, Li X, Zhang X, He X, Lai L, Liu Y, et al. The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: contribution of TSG-6. J Neuroinflammation. 2015;12:61. doi:10.1186/s12974-015-0284-x.CrossRefPubMedPubMedCentral

40.

Romanic AM, Madri JA. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 1994;4(2):145–56.CrossRefPubMed

41.

Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci. 2001;2(7):502–11. doi:10.1038/35081571.CrossRefPubMed

42.

Florczak-Rzepka M, Grond-Ginsbach C, Montaner J, Steiner T. Matrix metalloproteinases in human spontaneous intracerebral hemorrhage: an update. Cerebrovasc Dis 2012; 34(4):249–262. doi:10.1159/000341686.

43.

Chen S, Yang Q, Chen G, Zhang JH. An update on inflammation in the acute phase of intracerebral hemorrhage. Translational stroke research. 2015;6(1):4–8. doi:10.1007/s12975-014-0384-4.CrossRefPubMed

44.

Ortega FJ, Jolkkonen J, Mahy N, Rodriguez MJ. Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2013;33(3):356–64. doi:10.1038/jcbfm. 2012.166.CrossRef

Title: Role of Glibenclamide in Brain Injury After Intracerebral Hemorrhage
Authors: Bing Jiang
Lin Li
Qianwei Chen
Yihao Tao
Liming Yang
Bo Zhang
John H. Zhang
Hua Feng
Zhi Chen
Jun Tang
Gang Zhu
Publication date: 01-04-2017
Publisher: Springer US
Published in: Translational Stroke Research / Issue 2/2017
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI: https://doi.org/10.1007/s12975-016-0506-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Role of Glibenclamide in Brain Injury After Intracerebral Hemorrhage

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2017

Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity

Association Between Dehydration and Short-Term Risk of Ischemic Stroke in Patients with Atrial Fibrillation

Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke

Pericytes in Brain Injury and Repair After Ischemic Stroke

Induction of Perivascular Neural Stem Cells and Possible Contribution to Neurogenesis Following Transient Brain Ischemia/Reperfusion Injury

Stroke Cytoprotection: Can Repeating History with New Expectations Really Be the Path to Success in Stroke Research?